Clinical Trial Update: Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study [NA]

View source ↗

Summary

The ANRS EP 44 trial reports on residual HIV-1 replication in gut-associated lymphoid tissue in patients on HAART, with the study status now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV Infection | NA | Status: COMPLETED